Biogen Inc. vs DexCom, Inc.
μκ°μ λ°λ₯Έ μκ°μ΄μ‘ λΉκ΅
Biogen Inc.
$30.9B
μμ #301
DexCom, Inc.
$33.5B
μμ #297
μκ°μ λ°λ₯Έ μκ°μ΄μ‘
μ£Όμ μκ°
- DexCom, Inc.μ΄(κ°) 2021λ κΉμ§ Biogen Inc.μ(λ₯Ό) μΆμνμ΅λλ€
- Biogen Inc.μ΄(κ°) 2025λ κΉμ§ DexCom, Inc.μ(λ₯Ό) μΆμνμ΅λλ€
- DexCom, Inc.μ΄(κ°) 2026λ κΉμ§ Biogen Inc.μ(λ₯Ό) μΆμνμ΅λλ€
μ°λλ³ λΉκ΅
| μ°λ | Biogen Inc. | DexCom, Inc. | μ λ |
|---|---|---|---|
| 2026 | $30.9B | $33.5B | DexCom, Inc. |
| 2025 | $26.0B | $25.6B | Biogen Inc. |
| 2024 | $22.6B | $30.0B | DexCom, Inc. |
| 2023 | $38.2B | $47.9B | DexCom, Inc. |
| 2022 | $40.9B | $43.7B | DexCom, Inc. |
| 2021 | $35.4B | $51.8B | DexCom, Inc. |
| 2020 | $36.2B | $35.7B | Biogen Inc. |
| 2019 | $43.8B | $21.1B | Biogen Inc. |
| 2018 | $44.4B | $11.6B | Biogen Inc. |
| 2017 | $47.0B | $5.5B | Biogen Inc. |
| 2016 | $41.9B | $5.8B | Biogen Inc. |
| 2015 | $45.2B | $7.9B | Biogen Inc. |
| 2014 | $50.1B | $5.3B | Biogen Inc. |
| 2013 | $41.3B | $3.4B | Biogen Inc. |
| 2012 | $21.6B | $1.3B | Biogen Inc. |
| 2011 | $16.2B | $898.1M | Biogen Inc. |
| 2010 | $9.9B | $1.3B | Biogen Inc. |
| 2009 | $7.9B | $778.5M | Biogen Inc. |
| 2008 | $7.0B | $266.3M | Biogen Inc. |
| 2007 | $8.4B | $851.8M | Biogen Inc. |
| 2006 | $7.3B | $951.2M | Biogen Inc. |
| 2005 | $6.7B | $1.4B | Biogen Inc. |